NXP Semiconductors
NXPI · NasdaqSemiconductors & Related Devices · Fiscal year ends Dec 31
NXP Semiconductors reported revenue of $12.3B in the fiscal year ended Dec 2025, down 2.7% from the year before. Operating income was $3B, an operating margin of 24.8%, and net income was $2B. Operating cash flow of $2.8B less capital expenditure of $397M left free cash flow of $2.4B. Net debt was $9B.
Last 5 fiscal years
Revenue and net income
Income statement
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | $11.1B | $13.2B | $13.3B | $12.6B | $12.3B |
| Cost of revenue | $5B | $5.7B | $5.7B | $5.5B | $5.6B |
| Gross profit | $6.1B | $7.5B | $7.6B | $7.1B | $6.7B |
| Research & development | $1.9B | $2.1B | $2.4B | $2.3B | $2.4B |
| Selling, general & admin | $956M | $1.1B | $1.2B | $1.2B | $1.2B |
| Operating income | $2.6B | $3.8B | $3.7B | $3.4B | $3B |
| Interest expense | $369M | $427M | $438M | $398M | $466M |
| Pre-tax income | $2.2B | $3.4B | $3.4B | $3.1B | $2.7B |
| Income tax | $272M | $529M | $523M | $545M | $525M |
| Net income | $1.9B | $2.8B | $2.8B | $2.5B | $2B |
| Diluted EPS | 6.79 | 10.55 | 10.70 | 9.73 | 7.95 |
| Diluted shares | 276M | 264M | 261M | 258M | 254M |
Balance sheet
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Cash & equivalents | $2.8B | $3.8B | $3.9B | $3.3B | $3.3B |
| Receivables | $923M | $960M | $894M | $1B | $1.1B |
| Inventory | $1.2B | $1.8B | $2.1B | $2.4B | $2.6B |
| Current assets | $5.2B | $6.9B | $7.9B | $7.3B | $7.9B |
| Net PP&E | $2.6B | $3.1B | $3.3B | $3.3B | $3B |
| Goodwill | $10B | $9.9B | $10B | $9.9B | $10.3B |
| Total assets | $20.9B | $23.2B | $24.4B | $24.4B | $26.6B |
| Payables | $1.3B | $1.2B | $1.2B | $1B | $997M |
| Deferred revenue | – | – | $280M | $131M | $57M |
| Current liabilities | $2.5B | $3.3B | $4.1B | $3.1B | $3.9B |
| Short-term debt | – | $0 | $1B | $500M | $1.3B |
| Long-term debt | $10.7B | $11.3B | $10.2B | $10.4B | $11B |
| Total liabilities | $14.1B | $15.5B | $15.4B | $14.9B | $16.1B |
| Shareholders' equity | $6.5B | $7.4B | $8.6B | $9.2B | $10.1B |
Cash flow
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating cash flow | $3.1B | $3.9B | $3.5B | $2.8B | $2.8B |
| Capital expenditure | $767M | $1.1B | $827M | $727M | $397M |
| Free cash flow | $2.3B | $2.8B | $2.7B | $2.1B | $2.4B |
| Depreciation & amortisation | $1.3B | $1.3B | $1.1B | $925M | $832M |
| Stock-based compensation | $353M | $364M | $411M | $461M | $462M |
| Acquisitions | $23M | $27M | $0 | $0 | $1.2B |
| Share buybacks | $4B | $1.4B | $1.1B | $1.4B | $899M |
| Dividends paid | $562M | $815M | $1B | $1B | $1B |
| Dividend per share | 2.25 | 3.38 | 4.06 | 4.06 | 4.06 |
Key ratios
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue growth (YoY) | – | 19.4% | 0.5% | −5.0% | −2.7% |
| Operating income growth (YoY) | – | 47.0% | −3.6% | −6.7% | −10.8% |
| EPS growth (YoY) | – | 55.4% | 1.4% | −9.1% | −18.3% |
| Gross margin | 54.8% | 56.9% | 56.9% | 56.4% | 54.7% |
| Operating margin | 23.3% | 28.8% | 27.6% | 27.1% | 24.8% |
| Net margin | 16.9% | 21.1% | 21.1% | 19.9% | 16.5% |
| Return on equityBlank when equity is negative | 28.7% | 37.4% | 32.4% | 27.3% | 20.1% |
| ROCEEBIT ÷ (assets − current liabilities) | 14.0% | 19.0% | 18.1% | 16.1% | 13.4% |
| Free cash flow margin | 20.9% | 21.4% | 20.2% | 16.3% | 19.7% |
| Cash conversion (CFO ÷ net income) | 1.64x | 1.40x | 1.26x | 1.11x | 1.40x |
| Receivable days | 30 | 27 | 25 | 30 | 31 |
| Inventory days | 87 | 114 | 136 | 156 | 169 |
| Payable days | 91 | 76 | 74 | 68 | 66 |
| Interest cover | 7.00x | 8.89x | 8.36x | 8.59x | 6.54x |
| Debt ÷ equity | 1.63x | 1.51x | 1.29x | 1.18x | 1.22x |
| Net debtDebt − cash & equivalents; excludes investments; negative = net cash | $7.8B | $7.4B | $7.3B | $7.6B | $9B |
| Current ratio | 2.13x | 2.12x | 1.91x | 2.36x | 2.05x |
Recent filings
More in Semiconductors & Related Devices
Standardised figures from the company's XBRL filings with the SEC (10-K, 10-Q). Line items follow US GAAP tags, so a company's own statement layout may differ and some lines show “–” where the company does not report that item. Ratios are calculated from these figures. For education only; not investment advice or a recommendation.